Iradimed (IRMD) EBT Growth (5y) (2018 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Iradimed | 1.17 Bn | 1.11 Bn | 16.81 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 34.40% |
| Dec 31, 2025 | 63.61% |
| Sep 30, 2025 | 55.83% |
| Jun 30, 2025 | 35.20% |
| Mar 31, 2025 | 48.05% |
| Dec 31, 2024 | 21.93% |
| Sep 30, 2024 | 19.54% |
| Jun 30, 2024 | 20.64% |
| Mar 31, 2024 | 26.69% |
| Dec 31, 2023 | 24.81% |
| Sep 30, 2023 | 33.87% |
| Jun 30, 2023 | 25.48% |
| Mar 31, 2023 | 31.00% |
| Dec 31, 2022 | 35.45% |
| Sep 30, 2022 | 79.92% |
| Jun 30, 2022 | 64.34% |
| Mar 31, 2022 | 75.50% |
| Dec 31, 2021 | 15.50% |
| Sep 30, 2021 | 3.62% |
| Jun 30, 2021 | -11.05% |
| Mar 31, 2021 | -12.80% |
| Dec 31, 2020 | -27.49% |
| Sep 30, 2020 | -24.64% |
| Jun 30, 2020 | -25.09% |
| Mar 31, 2020 | -18.41% |
| Dec 31, 2019 | 69.04% |
| Sep 30, 2019 | 45.91% |
| Jun 30, 2019 | 8.64% |
| Mar 31, 2019 | 14.19% |
| Dec 31, 2018 | 22.46% |
| Sep 30, 2018 | 31.81% |
| Jun 30, 2018 | 16.25% |